Cargando…
Beyond the Present Constraints That Prevent a Wide Spread of Tissue Engineering and Regenerative Medicine Approaches
Despite the success of tissue engineered medical products (TEMPs) in preclinical translational research, very few have had success in the clinical market place. This gap, referred to as the “valley of death” is due to the large number of ventures that failed to attract or retain investor funding, pr...
Autores principales: | O'Donnell, Benjamen T., Ives, Clara J., Mohiuddin, Omair A., Bunnell, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514054/ https://www.ncbi.nlm.nih.gov/pubmed/31134194 http://dx.doi.org/10.3389/fbioe.2019.00095 |
Ejemplares similares
-
Adipose Stem Cells in Regenerative Medicine: Looking Forward
por: Al-Ghadban, Sara, et al.
Publicado: (2022) -
Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs
por: Lin, Zixuan, et al.
Publicado: (2019) -
Decellularized Adipose Tissue Hydrogel Promotes Bone Regeneration in Critical-Sized Mouse Femoral Defect Model
por: Mohiuddin, Omair A., et al.
Publicado: (2019) -
A Review of Cellularization Strategies for Tissue Engineering of Whole Organs
por: Scarritt, Michelle E., et al.
Publicado: (2015) -
Use of Nanoparticles in Tissue Engineering and Regenerative Medicine
por: Fathi-Achachelouei, Milad, et al.
Publicado: (2019)